HOME >> BIOLOGY >> NEWS
The Cancer Genome Atlas awards funds for technology development

As part of The Cancer Genome Atlas (TCGA) pilot project, the National Institutes of Health (NIH) today awarded eight two-year grants totaling $3.4 million to support the development of innovative technologies for exploring the genomic underpinnings of cancer.

The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), both part of NIH, announced the TCGA pilot in December 2005 to test the feasibility of a large-scale, systematic approach to identifying the changes that occur in the genomes of cancer cells. The goal is to generate genomic information that the research community can use to develop new and improved strategies for detecting, treating and, ultimately, preventing cancer.

The types of tumors being studied in the pilot include brain cancer (glioblastoma), ovarian cancer and lung cancer (squamous cell), which together account for more than 200,000 cases of cancer in the United States each year.

In addition to the detailed genomic data it will generate, there is great hope that TCGA will both advance technological development and drive down its cost, said NCI Director John E. Niederhuber, M.D. Our greatest challenge will be in applying the volumes of information TCGA will provide about tumors to the genomic data NCI is gathering from large cohorts of patients, in order to better predict, and even prevent, the earliest development of cancer.

Cancer poses a very complex challenge. Each of the dozens of types of cancer likely will have a different genomic profile or set of profiles. We urgently need tools equal to this task, said NHGRI Director Francis S. Collins, M.D., Ph.D., whose institute led the NIH component of the Human Genome Project. One of the major lessons we learned from the Human Genome Project is that technology development is essential for success.

The institutions and principal investigators chosen to receive the two-year grants are:

  • Baylor
    '"/>


Contact: Geoff Spencer
spencerg@mail.nih.gov
301-402-0911
NIH/National Human Genome Research Institute
2-Jul-2007


Page: 1 2 3

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Cancer cures could work for canines and humans
3. Cancer research specialist and HSPH professor awarded Medal of Honor from WHO cancer agency
4. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
5. Cancer stem cells can go it alone
6. Cancer drug enhances long-term memory
7. Cancer cells reprogram energy needs to grow and spread, study suggests
8. Cancer scientists create human leukemia process to map how disease begins, progresses
9. Cancer tip -- Nanoparticles can damage DNA, increase cancer risk
10. Other highlights from the April 18 Journal of the National Cancer Institute
11. American Association for Cancer Research provides support for promising cancer scientists

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/9/2019)... ... November 08, 2019 , ... SiteSeer Technologies, creator of SiteSeer Professional retail site ... and user of SiteSeer. The boutique real estate developer of single and multi-tenant buildings ... to supplement its own analysis of markets. , Geoffrey Kerth, manager of GPK ...
(Date:11/6/2019)... ... 2019 , ... In October, Massachusetts stem cell biotechnology company ... a poorly disclosed deficiency in stem cell treatments. Throughout stem cell medical ... stem cells. This problem affects all patients receiving stem cell treatments, including ...
(Date:11/2/2019)... ... October 31, 2019 , ... In this podcast, Smith spoke about the ... research and consulting. , The Beyond the Lab Podcast is an interview series initiated ... who have jobs in the biomedical field — and in these interviews, the alumni ...
Breaking Biology News(10 mins):
(Date:10/22/2019)... ... , ... Catalent, a global leader in clinical supply services, today announced that ... in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health ... on Oct. 28-30, 2019. , The panel session, on Wednesday, Oct. 30 at 8:30 ...
(Date:10/22/2019)... ... October 22, 2019 , ... DermBiont, a clinical stage ... DBI-001, met its primary safety endpoints, with no application site reactions and no ... the treatment of interdigital tinea pedis (athlete’s foot). Additionally, the trial demonstrated a ...
(Date:10/17/2019)... ... October 16, 2019 , ... ... genetic counseling information, has published a new white paper that explores how frequently ... guidance as to how patients and medical providers can be kept informed as ...
(Date:10/10/2019)... ... October 09, 2019 , ... ... MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the ... in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine ...
Breaking Biology Technology:
Cached News: